These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 7907835)
41. Covalent blocking of fibril formation and aggregation of intracellular amyloidgenic proteins by transglutaminase-catalyzed intramolecular cross-linking. Konno T; Morii T; Hirata A; Sato S; Oiki S; Ikura K Biochemistry; 2005 Feb; 44(6):2072-9. PubMed ID: 15697232 [TBL] [Abstract][Full Text] [Related]
42. Molecular cloning and expression of Caenorhabditis elegans ERp57-homologue with transglutaminase activity. Natsuka S; Takubo R; Seki R; Ikura K J Biochem; 2001 Dec; 130(6):731-5. PubMed ID: 11726271 [TBL] [Abstract][Full Text] [Related]
43. Cross-linking of a synthetic partial-length (1-28) peptide of the Alzheimer beta/A4 amyloid protein by transglutaminase. Ikura K; Takahata K; Sasaki R FEBS Lett; 1993 Jul; 326(1-3):109-11. PubMed ID: 8100780 [TBL] [Abstract][Full Text] [Related]
44. Transglutaminase facilitates the formation of polymers of the beta-amyloid peptide. Dudek SM; Johnson GV Brain Res; 1994 Jul; 651(1-2):129-33. PubMed ID: 7922559 [TBL] [Abstract][Full Text] [Related]
45. Arterial vimentin is a transglutaminase substrate: a link between vasomotor activity and remodeling? Gupta M; Greenberg CS; Eckman DM; Sane DC J Vasc Res; 2007; 44(5):339-44. PubMed ID: 17476115 [TBL] [Abstract][Full Text] [Related]
46. Transglutaminase 6: a protein associated with central nervous system development and motor function. Thomas H; Beck K; Adamczyk M; Aeschlimann P; Langley M; Oita RC; Thiebach L; Hils M; Aeschlimann D Amino Acids; 2013 Jan; 44(1):161-77. PubMed ID: 21984379 [TBL] [Abstract][Full Text] [Related]
47. Assays for the measurement of tissue transglutaminase (type II) mediated protein crosslinking via epsilon-(gamma-glutamyl) lysine and N',N'-bis (gamma-glutamyl) polyamine linkages using biotin labelled casein. Lilley GR; Griffin M; Bonner PL J Biochem Biophys Methods; 1997 Feb; 34(1):31-43. PubMed ID: 9089382 [TBL] [Abstract][Full Text] [Related]
48. Addressing substrate glutamine requirements for tissue transglutaminase using substance P analogues. Pastor MT; Diez A; Pérez-Payá E; Abad C FEBS Lett; 1999 May; 451(3):231-4. PubMed ID: 10371195 [TBL] [Abstract][Full Text] [Related]
49. Transglutaminase expression in rat parotid gland after isoproterenol stimulation. Cocuzzi E; Kim HC; Beninati S; Hand AR; Chung SI J Dent Res; 1989 Nov; 68(11):1474-8. PubMed ID: 2573623 [TBL] [Abstract][Full Text] [Related]
50. Localization of the transglutaminase cross-linking sites in the Bacillus subtilis spore coat protein GerQ. Monroe A; Setlow P J Bacteriol; 2006 Nov; 188(21):7609-16. PubMed ID: 16936016 [TBL] [Abstract][Full Text] [Related]
51. Characterisation of a novel cold-adapted calcium-activated transglutaminase: implications for medicine and food processing. Alvarez RG; Karki P; Langleite IE; Bakksjø RJ; Eichacker LA; Furnes C FEBS Open Bio; 2020 Apr; 10(4):495-506. PubMed ID: 32115900 [TBL] [Abstract][Full Text] [Related]
52. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking. Achyuthan KE; Dobson JV; Greenberg CS Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839 [TBL] [Abstract][Full Text] [Related]
53. The role of transglutaminase-2 and its substrates in human diseases. Facchiano F; Facchiano A; Facchiano AM Front Biosci; 2006 May; 11():1758-73. PubMed ID: 16368554 [TBL] [Abstract][Full Text] [Related]
54. Transglutaminase activity, protein, and mRNA expression are increased in progressive supranuclear palsy. Zemaitaitis MO; Kim SY; Halverson RA; Troncoso JC; Lee JM; Muma NA J Neuropathol Exp Neurol; 2003 Feb; 62(2):173-84. PubMed ID: 12578227 [TBL] [Abstract][Full Text] [Related]
55. Biochemical mechanisms for a possible involvement of the transglutaminase activity in the pathogenesis of the polyglutamine diseases: minireview article. Pepe I; Occhino E; Cella G; Luongo A; Guardascione F; Gentile V Amino Acids; 2004 Jul; 26(4):431-4. PubMed ID: 15290350 [TBL] [Abstract][Full Text] [Related]
56. Assessing the Catalytic Activity of Transglutaminases in the Context of Autophagic Responses. D'Eletto M; Farrace MG; Piacentini M; Rossin F Methods Enzymol; 2017; 587():511-520. PubMed ID: 28253975 [TBL] [Abstract][Full Text] [Related]
57. Identification of new amine acceptor protein substrate candidates of transglutaminase in rat liver extract: use of 5-(biotinamido) pentylamine as a probe. Ichikawa A; Ishizaki J; Morita M; Tanaka K; Ikura K Biosci Biotechnol Biochem; 2008 Apr; 72(4):1056-62. PubMed ID: 18391459 [TBL] [Abstract][Full Text] [Related]
58. Isolation and characterization of the human tissue transglutaminase gene promoter. Lu S; Saydak M; Gentile V; Stein JP; Davies PJ J Biol Chem; 1995 Apr; 270(17):9748-56. PubMed ID: 7730352 [TBL] [Abstract][Full Text] [Related]
59. Biotinylated peptides containing a factor XIIIa or a tissue transglutaminase-reactive glutaminyl residue that block protein cross-linking phenomena by becoming incorporated into amine donor sites. Lorand L; Parameswaran KN; Velasco PT; Murthy SN Bioconjug Chem; 1992; 3(1):37-41. PubMed ID: 1352131 [TBL] [Abstract][Full Text] [Related]
60. Immunoblot analysis reveals that isopeptide antibodies do not specifically recognize the epsilon-(gamma-glutamyl)lysine bonds formed by transglutaminase activity. Johnson GV; LeShoure R J Neurosci Methods; 2004 Apr; 134(2):151-8. PubMed ID: 15003381 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]